Impact of platelet characteristics on post‐transfusion count response in critically ill children on Extracorporeal Membrane Oxygenation : A secondary analysis of the ECSTATIC trial
Transfusion · 2026
DOI: 10.1111/trf.70299 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Transfusion, 2026. Verfasst von Oliver Karam und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Pediatric Critical Care Medicine, Yale, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Platelet Transfusion, Critical Illness, Blood Platelets. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart, Lung, and Blood Institute.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background Children supported by extracorporeal membrane oxygenation (ECMO) frequently receive platelet transfusions. However, little is known about how characteristics of platelet products affect transfusion effectiveness in ECMO patients. Our objective was to evaluate whether platelet product characteristics were associated with platelet count increment. Study Design and Methods Secondary analysis of the ECSTATIC randomized controlled trial. Children
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Pediatric Critical Care Medicine, Yale, New Haven, Connecticut, USA.
- Utah Data Coordinating Center and Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Rochester Golisano Children's Hospital, Rochester, New York, USA.
- Divisions of Pediatric Critical Care Medicine and Pediatric Cardiology, Morgan Stanley Children's Hospital at Columbia University School of Medicine, New York, New York, USA.
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Louisville Norton Children's Hospital, Louisville, Kentucky, USA.
- Pediatric Critical Care Medicine, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Oliver Karam, Jamie Furlong-Dillard, Robert A Niebler, Madhuradhar Chegondi, Marianne E Nellis
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Karam, O., Barney, B. J., Coles, G., Choudhury, T. A., Furlong-Dillard, J., Ozment, C., Bain, J., Niebler, R. A., Chegondi, M., Schiller, O., Joashi, U., Paden, M., Nellis, M. E., ECSTATIC collaborators, & Blood Net and PediECMO, subgroups of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) (2026). Impact of platelet characteristics on post‐transfusion count response in critically ill children on Extracorporeal Membrane Oxygenation : A secondary analysis of the ECSTATIC trial. Transfusion. https://doi.org/10.1111/trf.70299
Vancouver
Karam O, Barney BJ, Coles G, Choudhury TA, Furlong-Dillard J, Ozment C, et al. Impact of platelet characteristics on post‐transfusion count response in critically ill children on Extracorporeal Membrane Oxygenation : A secondary analysis of the ECSTATIC trial. Transfusion. 2026. doi:10.1111/trf.70299
BibTeX
@article{Karam2026,
author = {Karam, Oliver and Barney, Bradley J and Coles, Garrett and Choudhury, Tarif A and Furlong-Dillard, Jamie and Ozment, Caroline and Bain, Jesse and Niebler, Robert A and Chegondi, Madhuradhar and Schiller, Ofer and Joashi, Umesh and Paden, Matthew and Nellis, Marianne E and ECSTATIC collaborators, ECSTATIC collaborators and Blood Net and PediECMO, subgroups of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), Blood Net and PediECMO, subgroups of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI)},
title = {Impact of platelet characteristics on post‐transfusion count response in critically ill children on Extracorporeal Membrane Oxygenation : A secondary analysis of the ECSTATIC trial},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70299}
}
EUVIMED